CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Reckitt Benckiser Pharmaceutical

For profitContributed to NMEWebsite ↗

Also known as: Rb Hlth | RB HLTH | Reckitt Benckiser | RECKITT BENCKISER | Reckitt Benckiser Healthcare (UK) Limited | Reckitt Benckiser Inc. | Reckitt Benckiser LLC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2005

First marketed drug

Jul 1, 1999

Last known activity

Dec 22, 2025

Timeline

1980s

  1. Oct 8, 1982

    dextromethorphan— NDA Organization

1990s

  1. Jan 1, 1999

    Benckiser NV— Acquired

  2. Jan 1, 1999

    Reckitt and Colman— Acquired

  3. Jul 1, 1999

    Reckitt Benckiser Pharmaceutical— Founded

2000s

  1. Jul 12, 2002

    guaifenesin— NDA Secondary Org

  2. Dec 10, 2007

    Adams Respiratory Therapeutics— Acquired

2010s

  1. Jan 1, 2012

    Schiff Nutrition— Acquired

  2. Jun 5, 2015

    norgestrel— Marketing Organization

Drugs by trial phase (15 distinct, 42 trials)

Phase 4 (1 own, 3 via acquisition)

Phase 2 (1 own, 1 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (4)

Subsidiaries (4 direct, 6 total across the full acquisition tree)

Recent trials (43)

Details

Founded
Slough, GB Jul 1, 1999
Last known activity
Dec 22, 2025